Cargando…
Utilization of Gelling Polymer to Formulate Nanoparticles Loaded with Epalrestat-Cyclodextrin Inclusion Complex: Formulation, Characterization, In-Silico Modelling and In-Vivo Toxicity Evaluation
Epalrestat (EPL) is an aldose reductase inhibitor with poor aqueous solubility that affects its therapeutic efficacy. The research study was designed to prepare epalrestat-cyclodextrins (EPL-CDs) inclusion complexes to enhance the aqueous solubility by using beta-cyclodextrin (β-CD) and sulfobutyl e...
Autores principales: | Alvi, Zunaira, Akhtar, Muhammad, Rahman, Nisar U., Hosny, Khaled M., Sindi, Amal M., Khan, Barkat A., Nazir, Imran, Sadaquat, Hadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708980/ https://www.ncbi.nlm.nih.gov/pubmed/34960901 http://dx.doi.org/10.3390/polym13244350 |
Ejemplares similares
-
Enhanced Oral Bioavailability of Epalrestat SBE(7)-β-CD Complex Loaded Chitosan Nanoparticles: Preparation, Characterization and in-vivo Pharmacokinetic Evaluation
por: Alvi, Zunaira, et al.
Publicado: (2021) -
Inclusion Complexes of Rifampicin with Native and Derivatized Cyclodextrins: In Silico Modeling, Formulation, and Characterization
por: Anjani, Qonita Kurnia, et al.
Publicado: (2021) -
Formulation and Characterization of Epalrestat-Loaded Polysorbate 60 Cationic Niosomes for Ocular Delivery
por: Kattar, Axel, et al.
Publicado: (2023) -
Parietin Cyclodextrin-Inclusion Complex as an Effective Formulation for Bacterial Photoinactivation
por: Ayoub, Abdallah Mohamed, et al.
Publicado: (2022) -
Formulation mathématique du modèle de Gell-Mann
por: d'Espagnat, Bernard, et al.
Publicado: (1956)